Abstract
A massive, locally extensive adenocarcinoma of the prostate (2,246 ccm) presenting as constipation and a palpable abdominal mass, was treated with androgen deprivation resulting in a 94 percent reduction in tumor size, and relief of symptoms. Serum prostate-specific antigen was reduced from 4,029 to 0.4 ng/mL, after hormonal therapy was combined with radiation treatments for local disease control.
MeSH terms
-
Adenocarcinoma / complications
-
Adenocarcinoma / pathology*
-
Adenocarcinoma / therapy
-
Aged
-
Combined Modality Therapy
-
Constipation / etiology
-
Flutamide / therapeutic use
-
Humans
-
Leuprolide / therapeutic use
-
Male
-
Prostate / pathology*
-
Prostate-Specific Antigen / blood
-
Prostatic Neoplasms / complications
-
Prostatic Neoplasms / pathology*
-
Prostatic Neoplasms / therapy
-
Radiotherapy Dosage
Substances
-
Flutamide
-
Prostate-Specific Antigen
-
Leuprolide